SOME ANTINEOPLASTIC ANTIBIOTICS

[21] BACHUR NR, 1970, CANCER CHEMOTH REP 1, V54, P89

[22] BACHUR NR, 1971, J PHARMACOL EXP THER, V177, P567

[23] BACHUR NR, 1971, J PHARMACOL EXP THER, V177, P573

[24] POTENTIAL ANTI-CANCER AGENTS .2. A PROPOSED MECHANISM FOR THE ANTI-CANCER ACTION OF L-AZASERINE AND 6-DIAZO-5-OXO-L-NORLEUCINE [J]. BIOCHEMICAL PHARMACOLOGY, 1959, 2 (03) : 161 - 167

[25] BAKER BR, 1959, CANCER CHEMOTH REP, P1

[26] BAKHAEVA GP, 1968, TETRAHEDRON LETT, P3595

[27] BALDINI L, 1962, ARCH ITAL PATOL CLIN, V5, P39

[28] BARBIERI P, 1964, GIORN MICROBIOL, V12, P71

[29] Barclay RK, 1956, P AM ASSOC CANC RES, V2, P93

[30] BARG W, 1957, FED PROC, V16, P150

[21] BACHUR NR, 1970, CANCER CHEMOTH REP 1, V54, P89

[22] BACHUR NR, 1971, J PHARMACOL EXP THER, V177, P567

[23] BACHUR NR, 1971, J PHARMACOL EXP THER, V177, P573

[24] POTENTIAL ANTI-CANCER AGENTS .2. A PROPOSED MECHANISM FOR THE ANTI-CANCER ACTION OF L-AZASERINE AND 6-DIAZO-5-OXO-L-NORLEUCINE [J]. BIOCHEMICAL PHARMACOLOGY, 1959, 2 (03) : 161 - 167

[25] BAKER BR, 1959, CANCER CHEMOTH REP, P1

[26] BAKHAEVA GP, 1968, TETRAHEDRON LETT, P3595

[27] BALDINI L, 1962, ARCH ITAL PATOL CLIN, V5, P39

[28] BARBIERI P, 1964, GIORN MICROBIOL, V12, P71

[29] Barclay RK, 1956, P AM ASSOC CANC RES, V2, P93

[30] BARG W, 1957, FED PROC, V16, P150